# Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

> **NCT07687186** · PHASE3 · RECRUITING · sponsor: **Tasly Pharmaceutical Group Co., Ltd** · enrollment: 636 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Qishen Yiqi Dripping Pills 2 bags
- **DRUG:** Qishen Yiqi Dripping Pills placebo 2 bags

## Key facts

- **NCT ID:** NCT07687186
- **Lead sponsor:** Tasly Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2028-06-22
- **Final completion:** 2028-06-22
- **Target enrollment:** 636 (ESTIMATED)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687186, "Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07687186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*